As the only platform unifying all elements of the patient’s financial journey—including HSA banks and financial assistance programs—Cedar is uncovering unique pathways to affordability for patients
NEW YORK, Jan. 23, 2025 /PRNewswire/ — Cedar, the leading financial experience platform, has released Our Year in Review and Vision Ahead: Cedar’s Journey to Solving Healthcare’s Affordability Crisis, underscoring the company’s evolution from a patient engagement, billing, and collections platform to a comprehensive affordability solution. Through new investments in GenerativeAI and an expanding ecosystem of partnerships, Cedar is uniquely positioned to address affordability and define excellence in patient financial experience.
“We started with a simple belief: paying medical bills should be as easy as an online purchase. That vision helped us revolutionize medical billing for nearly 50 million patients. But, the rapidly increasing cost of care is preventing too many of these patients from receiving the care they need,” said Florian Otto, CEO and Co-founder of Cedar. “Our 2024 initiatives, from AI-powered solutions to comprehensive affordability pathways, demonstrate that we can make healthcare financially accessible while supporting providers’ sustainability.”
Key milestones from the report include:
Looking ahead to 2025, Cedar will continue investing in new affordability pathways—including ACA coverage and Medicare Advantage supplemental benefits—and AI-driven patient support to further ensure that paying for healthcare never compromises health.
Our Year in Review and Vision Ahead: Cedar’s Journey to Solving Healthcare’s Affordability Crisis is available to download at www.cedar.com.
About Cedar
Cedar is the leading financial experience platform for healthcare providers who prioritize patients. Cedar delivers healthcare’s top patient financial experience platform for modern revenue cycle teams. Starting with consumer-grade technology, we offer the only platform that integrates a patient’s billing and benefits information in one simple payment experience. Our platform is a must-have for finance leaders to increase patient payments while boosting patient loyalty. To learn more, visit www.cedar.com and join us on LinkedIn, X, and YouTube.
Contact
For Cedar
Jenny Fiegoli
press@cedar.com
SOURCE Cedar
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…